PA

Perceptive Advisors Portfolio holdings

AUM $2.67B
This Quarter Return
-4.87%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$7.52B
AUM Growth
+$7.52B
Cap. Flow
-$663M
Cap. Flow %
-8.82%
Top 10 Hldgs %
42.45%
Holding
173
New
32
Increased
18
Reduced
39
Closed
33

Top Buys

1
LABP
Landos Biopharma, Inc. Common Stock
LABP
$141M
2
BBIO icon
BridgeBio Pharma
BBIO
$64.7M
3
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
$55.4M
4
SWTX
SpringWorks Therapeutics
SWTX
$49.5M
5
EXAS icon
Exact Sciences
EXAS
$46.6M

Top Sells

1
NVAX icon
Novavax
NVAX
$116M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$95.2M
3
NBIX icon
Neurocrine Biosciences
NBIX
$93.1M
4
EIDX
Eidos Therapeutics, Inc. Common Stock
EIDX
$90.4M
5
NVTA
Invitae Corporation
NVTA
$73.5M

Sector Composition

1 Healthcare 84.38%
2 Financials 0.28%
3 Industrials 0.21%
4 Consumer Discretionary 0.02%
5 Materials 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
DRIO icon
101
DarioHealth
DRIO
$22.6M
$6.31M 0.08%
+327,869
New +$6.31M
AMWL icon
102
American Well
AMWL
$112M
$6.17M 0.08%
355,000
-170,000
-32% -$2.95M
SNDX icon
103
Syndax Pharmaceuticals
SNDX
$1.39B
$6.04M 0.08%
270,000
-30,000
-10% -$671K
VINC
104
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$5.79M 0.07%
300,000
– –
ATXS icon
105
Astria Therapeutics
ATXS
$394M
$5.59M 0.07%
+1,933,551
New +$5.59M
TNGX icon
106
Tango Therapeutics
TNGX
$745M
$5.56M 0.07%
500,000
– –
PHR icon
107
Phreesia
PHR
$1.81B
$5.21M 0.07%
100,000
– –
OBIO icon
108
Orchestra BioMed
OBIO
$147M
$5.04M 0.06%
450,000
– –
LGV.U
109
DELISTED
Longview Acquisition Corp. II Units, each consisting of one share of Class A Common Stock and one-fifth of one redeemable Warrant
LGV.U
$5.02M 0.06%
+500,000
New +$5.02M
CHFW.U
110
DELISTED
Consonance-HFW Acquisition Corp. Units, each consisting of one Class A Ordinary Share, and one-third
CHFW.U
$4.88M 0.06%
500,000
– –
DFHTU
111
DELISTED
Deerfield Healthcare Technology Acquisitions Corp. Unit
DFHTU
$3.93M 0.05%
300,000
– –
TXMD icon
112
TherapeuticsMD
TXMD
$12.7M
$3.69M 0.05%
+2,750,000
New +$3.69M
MRUS icon
113
Merus
MRUS
$5.04B
$3.66M 0.05%
+175,000
New +$3.66M
VRAY
114
DELISTED
ViewRay, Inc.
VRAY
$3.27M 0.04%
751,748
-1,700,000
-69% -$7.39M
TLIS
115
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
$3.21M 0.04%
+250,000
New +$3.21M
SNCE
116
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
$3.04M 0.04%
300,000
– –
SGTX
117
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
$2.79M 0.04%
125,000
– –
RGNX icon
118
Regenxbio
RGNX
$498M
$2.36M 0.03%
+69,283
New +$2.36M
GRTX
119
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$2.25M 0.03%
254,664
-70,336
-22% -$620K
MOTS
120
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
$2.07M 0.03%
1,800,542
-2,410,000
-57% -$2.77M
PLXP
121
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$2.01M 0.03%
+222,180
New +$2.01M
WGS icon
122
GeneDx Holdings
WGS
$3.65B
$1.89M 0.02%
+127,000
New +$1.89M
BFLY.WS icon
123
Butterfly Network, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share
BFLY.WS
$11.1M
$1.51M 0.02%
+233,333
New +$1.51M
RACE icon
124
Ferrari
RACE
$88.2B
$1.3M 0.02%
6,200
– –
EIGR
125
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$1.24M 0.02%
139,890
– –
3 4
5
6 7